This article summarizes the top insider buys and sells for US stocks reported on Thursday, March 20, 2025.

Top Insider Buys:

Staar Surgical Co. (NASDAQ: STAA )

Broadwood Partners, L.P. has significantly increased its stake in Staar Surgical Co. by purchasing 201,844 shares of common stock. The transactions, which occurred on March 18 and March 20, 2025, were executed at prices ranging from $16.58 to $17.99 per share, totaling approximately $3.6 million. This investment comes as the stock trades near its Fair Value, with shares down over 54% in the past year. Following these purchases, Broadwood Partners now holds over 12 million shares of Staar Surgical, a company specializing in ophthalmic goods.

Cartesian Therapeutics, Inc. (NASDAQ: RNAC )

Timothy A. Springer, a director and significant shareholder of Cartesian Therapeutics, Inc., acquired a substantial amount of the company’s common stock. Over a three-day period ending March 20, 2025, Springer purchased a total of 89,863 shares, with an aggregate value exceeding $1.37 million. The transactions were conducted at weighted average prices ranging from $14.42 to $15.59 per share. Following these purchases, Springer’s direct ownership increased to 8,621,325 shares, with additional indirect ownership through his wife and TAS Partners LLC.

Asana, Inc. (NYSE: ASAN )

Dustin Moskovitz, the President, CEO, and Chair of Asana, Inc., acquired 675,000 shares of the company’s Class A Common Stock over three consecutive days, from March 18 to March 20, 2025. The shares were bought at a weighted average price within the range of $14.03 to $14.34 per share, amounting to a total investment of approximately $9.55 million. These purchases were executed under a previously adopted Rule 10b5-1 trading plan and increased Moskovitz’s direct ownership to 49,248,436 shares.

BlackRock (NYSE: BLK ) ESG Capital Allocation Term Trust (NYSE: ECAT )

BlackRock, Inc. increased its stake in BlackRock ESG Capital Allocation Term Trust by purchasing 101,600 common shares at a weighted average price of $16.31, totaling approximately $1.66 million. This transaction boosted BlackRock’s direct ownership to 1,075,200 shares in the $1.65 billion market cap trust, which currently offers a 22.66% dividend yield.

Globalstar, Inc. (NYSE:NASDAQ: GSAT )

Monroe James III, a director and significant stakeholder of Globalstar, Inc., acquired 25,000 shares of the company’s voting common stock through Thermo Properties II, LLC. The shares were purchased at a volume-weighted average price of $21.8312, totaling approximately $545,780. This acquisition adds to Monroe’s substantial stake in the satellite communications company.

Top Insider Sells:

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS )

Bobak Azamian, the President, CEO, and Board Chair of Tarsus Pharmaceuticals, Inc., sold 24,216 shares of the company’s stock valued at approximately $1.16 million. The transactions took place over three days from March 18 to March 20, at prices ranging from $46.29 to $50.11 per share. These sales were executed to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units.

Atlassian Corp (NASDAQ: TEAM )

Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp, sold shares totaling approximately $1.82 million on March 19. The transactions were executed at prices ranging from $221.04 to $232.84 per share. Following these sales, Cannon-Brookes retains ownership of 63,584 shares, held indirectly through a trust.

Atlassian Corp (NASDAQ: TEAM )

Scott Farquhar, co-founder and director of Atlassian Corp, disposed of approximately 7,048 shares of the company’s Class A common stock on March 19. The transactions were executed at prices ranging from $221.04 to $232.84 per share, totaling approximately $1.82 million. These sales were conducted through a Rule 10b5-1 trading plan.

WillScot Holdings Corp (NASDAQ: WSC )

Erik Olsson, a director at WillScot Holdings Corp, sold 110,307 shares of the company’s common stock on March 18, 2025, at a weighted average price of $30.19 per share, amounting to approximately $3.3 million. In conjunction with this sale, Olsson exercised stock options to acquire the same number of shares at a price of $10.91 each.

St Joe Co (NYSE: JOE )

Fairholme Funds Inc., under the management of Bruce R. Berkowitz, sold 220,400 shares of St Joe Co over three days, from March 18 to March 20, 2025, at prices ranging from $47.00 to $47.01 per share. This transaction amounted to a total value of approximately $10.36 million.

Investors should stay tuned to insider buy and sell activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer important context when combined with other financial analysis and market research. It’s crucial to consider the broader picture, including company fundamentals, industry trends, and overall market conditions, when interpreting insider trading patterns.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.